NCT03845543View on ClinicalTrials.gov

Belgian-Italian Trial to Evaluate the Efficacy and Safety of Below The Knee (BTK) Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 28, 2018

Primary Completion Date

July 13, 2022

Study Completion Date

January 26, 2023

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Luminor-14 Paclitaxel eluting balloon

Patients will be treated with the Luminor-14 paclitaxel eluting balloon

Trial Locations (9)

2820

Imelda Hospital, Bonheiden

3300

Regionaal Ziekenhuis Heilig Hart, Tienen

3600

Z.O.L., Genk

8500

AZ Groeninge, Kortrijk

9200

A.Z. Sint-Blasius, Dendermonde

9300

OLV Ziekenhuis Aalst, Aalst

20097

IRCCS Policlinico San Donato, San Donato

1-35031

Policlinico Abano Terme, Abano Terme

08916

Hospital Univ. Germans Trias I Pujol, Badalona

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT03845543 - Belgian-Italian Trial to Evaluate the Efficacy and Safety of Below The Knee (BTK) Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular | Biotech Hunter | Biotech Hunter